Clinical Trials Browser

Phase 2 × Sarcoma × olaratumab × Clear all

NCT03698227 2020-07-15

OlaReDo - Olaratumab and Rechallenge With Doxorubicin in Soft Tissue Sarcoma Patients

Phase 2 Terminated

Sarcoma